MedTrace Logo

Effect of Rasagiline on Balance in Parkinson's Disease as Measured by Computerized Posturography

NCT07077187 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2025-07-24

No results posted yet for this study

Summary

This study evaluates the effect of rasagiline on balance in Parkinson's disease. Participants taking study medication which is rasagiline or sugar pill will undergo a computerized balance test on and off medication. Participants will stand on a platform which which moves slightly and a computer will measure their body sway and provide a balance score.

Conditions

  • PARKINSON DISEASE (Disorder)

Interventions

DIAGNOSTIC_TEST

computerized dynamic posturography

Patients in each arm will have computerized dynamic posturography performed at baseline prior to taking first tablet as well as at 4 weeks and 8 weeks. In the adjuvant therapy arm, subjects will be evaluated on rasagiline but in a functional OFF state for their other Parkinson disease medications.

DRUG

Rasagiline 1 mg capsule

Rasagiline 1 mg oral tablet daily will be administered to study participants.

DRUG

Placebo

Placebo 1 mg oral tablet daily will be administered to study participants.

Sponsors & Collaborators

  • New York Medical College

    lead OTHER

Principal Investigators

  • Robert Fekete, MD · New York Medical College

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-15
Primary Completion
2017-07-10
Completion
2017-07-10
FDA Drug
Yes

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07077187 on ClinicalTrials.gov